Full history for every metric is available with a Kvantra account

Stock profile

Akoya Biosciences, Inc. (AKYA)

Country: United States of AmericaSector: HealthcareIndustry: Medical - Instruments & SuppliesExchange: NASDAQ

Delisted · last close 16 Jul 2025

Current price
1.29 USD0.00%
Last close 16 Jul 2025
Benchmarks

Key financial summary

Financials in USD
201920202021202220232024TTM
Total revenue$m42425575978280
Operating profit$m-47-39
Net profit$m-15-17-43-71-63-55-48
EPS reported$-1.12-0.97
Operating cashflow per share$-0.89-0.89
Capex per share$0.050.05
FCF per share$-0.94-0.94
Free cash flow$m-47-32
Net debt$m4149
Book value equity$m8-6
Book value per share$0.15-0.12
Number of sharesm49.4249.66
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
201920202021202220232024TTM
Value
P/E TTMx--
P/B LTMx14.90-10.94
P/S LTMx1.390.81
P/FCF LTMx-2.43-1.99
EV/EBITDA LTMx-5.00-3.82
EV/Sales LTMx2.271.42
Earnings Yield LTM%-48.92%-86.85%
FCF Yield%-41.14%-50.19%
Quality
ROE%-728.97%-180.44%
ROIC%-47.28%-47.28%
Operating margin%-57.22%-57.22%
Gross margin%58.62%58.62%
FCF/Sales%-57.01%-57.01%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%-15.48%-14.55%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-0.55-0.39
Net Debt/EBITDAx-1.95-1.95
EBIT/Net interestx-4.48-4.48
Net debt/market cap%36.35%75.95%
Net debt/Equityx5.42-8.31
Gross debt/equityx11.08-14.22

Company overview

Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product lineup features the PhenoCycler instrument, a compact benchtop fluidics system designed to integrate seamlessly with a microscope for automated image acquisition. Complementing this is the PhenoImager platform, which empowers researchers to intricately visualize, analyze, quantify, and characterize cells directly within diverse tissue samples—such as fresh frozen or FFPE sections and tissue microarrays—through an efficient, automated, and high-throughput process. Akoya also supplies the essential reagents for these PhenoCycler and PhenoImager systems, alongside providing specialized biopharmaceutical services. Beyond hardware, Akoya offers a robust suite of software tools. Proxima serves as a cloud-based platform for the secure storage, comprehensive analysis, and collaborative sharing of spatial data. For image interpretation, the inForm Tissue software delivers automated analysis to precisely visualize and quantify biomarkers within tissue sections. Further streamlining data workflows, Phenoptr facilitates the consolidation and in-depth analysis of output tables generated by inForm. Finally, phenoptrReports is a user-friendly software application that generates intuitive reports and visualizations from phenoptr output, presented via an easy-to-navigate graphical user interface. Established in 2015, Akoya Biosciences maintains its corporate headquarters in Marlborough, Massachusetts.

WebsiteN/A
IndustryMedical - Instruments & Supplies
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 16 Jul 2025

Akoya Biosciences, Inc. (AKYA)

AKYA · NASDAQ · Healthcare
1.29 USD0.00%
Benchmarks
Financialsin USD
20232024TTM
About

Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product lineup features the PhenoCycler instrument, a compact benchtop fluidics system designed to integrate seamlessly with a microscope for automated image acquisition. Complementing this is the PhenoImager platform, which empowers researchers to intricately visualize, analyze, quantify, and characterize cells directly within diverse tissue samples—such as fresh frozen or FFPE sections and tissue microarrays—through an efficient, automated, and high-throughput process. Akoya also supplies the essential reagents for these PhenoCycler and PhenoImager systems, alongside providing specialized biopharmaceutical services. Beyond hardware, Akoya offers a robust suite of software tools. Proxima serves as a cloud-based platform for the secure storage, comprehensive analysis, and collaborative sharing of spatial data. For image interpretation, the inForm Tissue software delivers automated analysis to precisely visualize and quantify biomarkers within tissue sections. Further streamlining data workflows, Phenoptr facilitates the consolidation and in-depth analysis of output tables generated by inForm. Finally, phenoptrReports is a user-friendly software application that generates intuitive reports and visualizations from phenoptr output, presented via an easy-to-navigate graphical user interface. Established in 2015, Akoya Biosciences maintains its corporate headquarters in Marlborough, Massachusetts.

IndustryMedical - Instruments & Supplies
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free